Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US2561352038

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 181,298 186,756 189,722 194,741 203,406 207,307 214,391 217,351 222,776 237,279 245,879 261,109 266,854 271,302 279,164 288,507 299,867 311,305 325,535 334,260
Change (%) 3.01 1.59 2.65 4.45 1.92 3.42 1.38 2.50 6.51 3.62 6.19 2.20 1.67 2.90 3.35 3.94 3.81 4.57 2.68
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 83,604 86,246 86,645 90,720 95,008 96,835 100,551 103,204 102,168 105,190 106,536 108,219 110,843 113,181 115,557 118,109 122,068 126,657 135,107 141,549
Change (%) 3.16 0.46 4.70 4.73 1.92 3.84 2.64 -1.00 2.96 1.28 1.58 2.42 2.11 2.10 2.21 3.35 3.76 6.67 4.77
% of Revenue 46.11 46.18 45.67 46.58 46.71 46.71 46.90 47.48 45.86 44.33 43.33 41.45 41.54 41.72 41.39 40.94 40.71 40.69 41.50 42.35
Gross Operating Profit 97,694 100,510 103,077 104,021 108,398 110,472 113,840 114,147 120,608 132,089 139,343 152,890 156,011 158,121 163,607 170,398 177,799 184,648 190,428 192,711
Change (%) 2.88 2.55 0.92 4.21 1.91 3.05 0.27 5.66 9.52 5.49 9.72 2.04 1.35 3.47 4.15 4.34 3.85 3.13 1.20
% of Revenue 53.89 53.82 54.33 53.42 53.29 53.29 53.10 52.52 54.14 55.67 56.67 58.55 58.46 58.28 58.61 59.06 59.29 59.31 58.50 57.65
SG&A 50,740 52,457 54,650 56,849 59,693 60,717 62,081 62,529 63,138 65,708 68,026 70,235 72,470 74,717 77,201 81,910 86,402 89,274 92,853 95,809
Change (%) 3.38 4.18 4.02 5.00 1.72 2.25 0.72 0.97 4.07 3.53 3.25 3.18 3.10 3.32 6.10 5.48 3.32 4.01 3.18
% of Revenue 27.99 28.09 28.81 29.19 29.35 29.29 28.96 28.77 28.34 27.69 27.67 26.90 27.16 27.54 27.65 28.39 28.81 28.68 28.52 28.66
R&D 16,478 16,637 16,541 17,095 17,199 17,250 17,482 17,273 17,679 18,341 19,381 20,040 20,618 21,362 22,873 24,082 25,906 26,999 27,380 27,431
Change (%) 0.96 -0.58 3.35 0.61 0.30 1.34 -1.20 2.35 3.74 5.67 3.40 2.88 3.61 7.07 5.29 7.57 4.22 1.41 0.19
% of Revenue 9.09 8.91 8.72 8.78 8.46 8.32 8.15 7.95 7.94 7.73 7.88 7.67 7.73 7.87 8.19 8.35 8.64 8.67 8.41 8.21
OpEx 150,115 154,665 156,812 163,301 170,089 172,927 178,472 181,457 181,624 187,821 192,463 196,607 202,632 207,737 213,576 222,645 232,201 240,820 252,504 261,627
Change (%) 3.03 1.39 4.14 4.16 1.67 3.21 1.67 0.09 3.41 2.47 2.15 3.06 2.52 2.81 4.25 4.29 3.71 4.85 3.61
% of Revenue 82.80 82.82 82.65 83.86 83.62 83.42 83.25 83.49 81.53 79.16 78.28 75.30 75.93 76.57 76.51 77.17 77.43 77.36 77.57 78.27
Operating Income 31,183 32,091 32,910 31,440 33,317 34,380 35,919 35,894 41,152 49,458 53,416 64,502 64,222 63,565 66,208 65,862 67,666 70,485 73,031 72,633
Change (%) 2.91 2.55 -4.47 5.97 3.19 4.48 -0.07 14.65 20.18 8.00 20.75 -0.43 -1.02 4.16 -0.52 2.74 4.17 3.61 -0.54
% of Revenue 17.20 17.18 17.35 16.14 16.38 16.58 16.75 16.51 18.47 20.84 21.72 24.70 24.07 23.43 23.72 22.83 22.57 22.64 22.43 21.73
Interest Expense -867 -903 -970 -930 -912 -939 -958 -1,112 -1,187 -1,390 -1,428 -1,452 -1,496 -1,472 -1,711 -1,938 -2,342 -2,766 -2,829 -3,061
Change (%) 4.15 7.42 -4.12 -1.94 2.96 2.02 16.08 6.74 17.10 2.73 1.68 3.03 -1.60 16.24 13.27 20.85 18.10 2.28 8.20
% of Revenue -0.48 -0.48 -0.51 -0.48 -0.45 -0.45 -0.45 -0.51 -0.53 -0.59 -0.58 -0.56 -0.56 -0.54 -0.61 -0.67 -0.78 -0.89 -0.87 -0.92
Net Income 15,361 21,256 17,238 17,153 19,450 26,317 23,568 29,736 30,944 36,350 45,067 47,216 50,888 52,206 55,684 55,579 53,332 53,676 56,544 56,802
Change (%) 38.38 -18.90 -0.49 13.39 35.31 -10.45 26.17 4.06 17.47 23.98 4.77 7.78 2.59 6.66 -0.19 -4.04 0.65 5.34 0.46
% of Revenue 8.47 11.38 9.09 8.81 9.56 12.69 10.99 13.68 13.89 15.32 18.33 18.08 19.07 19.24 19.95 19.26 17.79 17.24 17.37 16.99

Source: Capital IQ

Other Listings
DE:RDDA € 12.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista